1982
DOI: 10.1111/j.1365-2044.1982.tb01154.x
|View full text |Cite
|
Sign up to set email alerts
|

Althesin infusions for maintenance of anaesthesia

Abstract: SummaryThe

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1983
1983
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…While thiopentone has been used for this purpose, its pharmacokinetic properties leave much to be desired, having an elimination half-life which is appreciably longer than that of methohexitone (Hudson et al 1982), which would seem to be the barbiturate of choice. The use of Althesin has been widely recommended for this purpose (Savege 1979, Towler et al 1982, although there may be a hazard from the effects of large doses of Cremophor: furthermore this drug could not safely be given to patients who have previously had a Cremophor-containing anaesthetic or who have a history of atopy or allergy (Clarke et al 1975, Fisher & More 1981.…”
mentioning
confidence: 99%
“…While thiopentone has been used for this purpose, its pharmacokinetic properties leave much to be desired, having an elimination half-life which is appreciably longer than that of methohexitone (Hudson et al 1982), which would seem to be the barbiturate of choice. The use of Althesin has been widely recommended for this purpose (Savege 1979, Towler et al 1982, although there may be a hazard from the effects of large doses of Cremophor: furthermore this drug could not safely be given to patients who have previously had a Cremophor-containing anaesthetic or who have a history of atopy or allergy (Clarke et al 1975, Fisher & More 1981.…”
mentioning
confidence: 99%
“…In the spontaneously breathing patient, infusion rates up to 4 times the maintenance rate led to only minor increases in Paco 2 . 5 Althesin also had little influence on renal or hepatic function 6,7 and appeared to be a useful anesthetic for the management of patients susceptible to malignant hyperthermia. However, it was considered unsafe in patients with acute porphyria.…”
Section: Alfaxalonementioning
confidence: 97%
“…This made it very popular in neurosurgical intensive care and for the management of head injuries. Fears developed about hypersensitivity reactions, the incidence of which has been variously estimated from 1:900 (32) to 1:10,000 (33), and resulted in the manufacturers withdrawing the agent in 1984. Concerns also developed about the hepatotoxic effects of its solubilizing agent, Cremaphor EL, which accumulated during infusion (34).…”
Section: Historymentioning
confidence: 99%